EXANE DERIVATIVES - NEWTEK BUSINESS SVCS CORP ownership

NEWTEK BUSINESS SVCS CORP's ticker is NEWT and the CUSIP is 652526203. A total of 82 filers reported holding NEWTEK BUSINESS SVCS CORP in Q2 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.0%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of NEWTEK BUSINESS SVCS CORP
ValueSharesWeighting
Q2 2022$16,466,000
-29.1%
8700.0%0.01%
+28.6%
Q1 2022$23,228,0008700.01%
Other shareholders
NEWTEK BUSINESS SVCS CORP shareholders Q2 2022
NameSharesValueWeighting ↓
&PARTNERS 77,726$1,755,0002.28%
Chubb Ltd 17,094$386,0001.79%
BARD ASSOCIATES INC 144,378$3,260,0001.66%
Intrinsic Edge Capital Management LLC 230,000$5,193,0000.58%
AMERICAN ASSET MANAGEMENT INC. 33,903$766,0000.53%
Bramshill Investments, LLC 98,115$2,215,0000.49%
Cavalier Investments, LLC 28,000$632,0000.27%
MCKINLEY CAPITAL MANAGEMENT LLC 137,893$3,114,0000.23%
NAVELLIER & ASSOCIATES INC 53,780$1,214,0000.20%
Axiom Investment Management LLC 10,172$230,0000.18%
View complete list of NEWTEK BUSINESS SVCS CORP shareholders